BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Growth Factor Complex	7765335653.00%
Growth Factor Complex Growth	18.21%
Plant Cell	1.98B
Plant Cell Growth	-43.60%
Extract	1.97B
Extract Growth	31.20%
Plant Cell Complex	1.60B
Plant Cell Complex Growth	-12.19%
Protein	1.48B
Protein Growth	29.95%
Peptide	941.03M
Peptide Growth	24.65%
Complex	86.83M
Complex Growth	58.73%
Manufactured Products - Other	71.89M
Manufactured Products - Other Growth	-22.69%
Research Service	45.00M
Research Service Growth	-52.11%
Other	128.42M
Other Growth	119.11%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
South Korea	13.26B
South Korea Growth	3.95%
China	1.35B
China Growth	-14.75%
Europe	238.81M
Europe Growth	-55.79%
Japan	219.80M
Japan Growth	-18.47%
Other	1.00B
Other Growth	124.23%

Data Source: Finnhub Last updated: Mar 31, 2026

Financial data is provided by Finnhub and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error